Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Videos

Counterpoint: Immunomodulator monotherapy should not be used in practice

Fernando Velayos, MD, codirector of the Crohn's and Colitis program at the University of California-San Francisco Medical Center, argues the case for why immunomodulators should not be used as monotherapy in treating inflammatory bowel disease.

Advertisement

Advertisement

Advertisement